Policy normalization and geopolitical threats are risks to growth.
Higher wages may outlast more transitory factors.
Pfizer and Moderna continue to come out on top.
Zero-Covid policies have been a drag on returns.
The bond market could derail policy-makers' plans if longer-term yields spike.
With default risk down, corporates should beat sovereigns again.
Without standards for investment products, transparency is essential.
Climate change commitments offer investing opportunities.
U.S. home prices are one of the few economic measures that didn't plunge during the pandemic.
Fixed income investors may need to look beyond sovereigns and investment-grade corporates.